Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Chi Lee

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 17, 2025
Bloodstream infections in hospitalized adults with COVID-19: clinical characteristics and outcomesPo-Hsuan Tseng, Ling-Shan Syue, Ching-Chi Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 15, 2024
Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemicYuan-Pin Hung, Ching-Chi Lee, Ying-Wen Chen, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?Yuan-Pin Hung, Jen-Chieh Lee, Chun-Wei Chiu, et al.
International Journal of Antimicrobial Agents|November 13, 2016
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemiaChih-Chia Hsieh, Chung-Hsun Lee, Ming-Yuan Hong, et al.
Diagnostic Microbiology and Infectious Disease|March 23, 2015
Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficialChing-Chi Lee, Nan-Yao Lee, Po-Lin Chen, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Predicting Bacteremia among Septic Patients Based on ED Information by Machine Learning Methods: A Comparative StudyVivian Goh, Yu-Jung Chou, Ching-Chi Lee, et al.
BMC Geriatrics|July 7, 2023
Effectiveness of outpatient geriatric evaluation and management intervention on survival and nursing home admission: a systematic review and meta-analysis of randomized controlled trialsPei-Chia Yen, Yu-Tai Lo, Chih-Cheng Lai, et al.
Journal of Global Antimicrobial Resistance|May 21, 2026
Association of prompt phenotype-desirable antimicrobial therapy with short-term mortality and hospital-onset Clostridioides difficile infection among adults with community-onset bacteraemiaChien-Hung Hou, Ya-Ching Hsu, Ching-Yu Ho, et al.
International Journal of Antimicrobial Agents|July 12, 2017
Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremiaChing-Chi Lee, Jiun-Ling Wang, Chung-Hsun Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 3, 2012
Non-typhoidal Salmonella bacteremia among adults: an adverse prognosis in patients with malignancyChia-Wen Li, Po-Lin Chen, Nan-Yao Lee, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 17, 2025
Bloodstream infections in hospitalized adults with COVID-19: clinical characteristics and outcomesPo-Hsuan Tseng, Ling-Shan Syue, Ching-Chi Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 15, 2024
Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemicYuan-Pin Hung, Ching-Chi Lee, Ying-Wen Chen, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?Yuan-Pin Hung, Jen-Chieh Lee, Chun-Wei Chiu, et al.
International Journal of Antimicrobial Agents|November 13, 2016
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemiaChih-Chia Hsieh, Chung-Hsun Lee, Ming-Yuan Hong, et al.
Diagnostic Microbiology and Infectious Disease|March 23, 2015
Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficialChing-Chi Lee, Nan-Yao Lee, Po-Lin Chen, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Predicting Bacteremia among Septic Patients Based on ED Information by Machine Learning Methods: A Comparative StudyVivian Goh, Yu-Jung Chou, Ching-Chi Lee, et al.
BMC Geriatrics|July 7, 2023
Effectiveness of outpatient geriatric evaluation and management intervention on survival and nursing home admission: a systematic review and meta-analysis of randomized controlled trialsPei-Chia Yen, Yu-Tai Lo, Chih-Cheng Lai, et al.
Journal of Global Antimicrobial Resistance|May 21, 2026
Association of prompt phenotype-desirable antimicrobial therapy with short-term mortality and hospital-onset Clostridioides difficile infection among adults with community-onset bacteraemiaChien-Hung Hou, Ya-Ching Hsu, Ching-Yu Ho, et al.
International Journal of Antimicrobial Agents|July 12, 2017
Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremiaChing-Chi Lee, Jiun-Ling Wang, Chung-Hsun Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 3, 2012
Non-typhoidal Salmonella bacteremia among adults: an adverse prognosis in patients with malignancyChia-Wen Li, Po-Lin Chen, Nan-Yao Lee, et al.
Pageof 15